CoChat
Sign Up
Cited by 26

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Inhibition of NF-κB signaling in IKKβF/F;LysM Cre mice causes motor deficits but does not alter pathogenesis of Spinocerebellar ataxia type 1

Ferro, Austin, Qu, Wenhui, Lukowicz, Abigail, Svedberg, Daniel, Johnson, Andrea, Cvetanovic, Marija·2018·PLOS ONE
DOI 10.1371/journal.pone.0200013PMC PMC6033432
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0200013

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 10 references

Research works printed but not linked: 75

  1. HT Orr, 2007, Trinucleotide Repeat Disorders, Annu. Rev. Neurosci, 30, 575, 10.1146/annurev.neuro.29.051605.113042 · DOI
  2. S Banfi, 1996, Cloning and developmental expression analysis of the murine homolog of the spinocerebellar ataxia type 1 gene (Sca1), Hum. Mol. Genet, 5, 33, 10.1093/hmg/5.1.33 · DOI
  3. HL Paulson, 2017, Polyglutamine spinocerebellar ataxias—from genes to potential treatments, Nat. Rev. Neurosci, 18, 613, 10.1038/nrn.2017.92 · DOI
  4. K Seidel, 2012, Brain pathology of spinocerebellar ataxias, Acta Neuropathol, 124, 1, 10.1007/s00401-012-1000-x · DOI
  5. A Matilla-Dueñas, 2008, Clinical, genetic, molecular, and pathophysiological insights into spinocerebellar ataxia type 1, Cerebellum, 7, 106, 10.1007/s12311-008-0009-0 · DOI
  6. G Oz, 2010, Neurochemical alterations in spinocerebellar ataxia type 1 and their correlations with clinical status, Mov. Disord, 25, 1253, 10.1002/mds.23067 · DOI
  7. G Oz, 2010, Noninvasive detection of presymptomatic and progressive neurodegeneration in a mouse model of spinocerebellar ataxia type 1, J. Neurosci, 30, 3831, 10.1523/JNEUROSCI.5612-09.2010 · DOI
  8. HY Zoghbi, 2009, Pathogenic mechanisms of a polyglutamine-mediated neurodegenerative disease, Spinocerebellar ataxia type 1, J. Biol. Chem, 284, 7425, 10.1074/jbc.R800041200 · DOI
  9. HE Nino, 1980, A family with hereditary ataxia: HLA typing 39, Neurology, 30, 12, 10.1212/WNL.30.1.12 · DOI
  10. M Cvetanovic, 2015, Early activation of microglia and astrocytes in mouse models of spinocerebellar ataxia type 1, Neuroscience, 289, 289, 10.1016/j.neuroscience.2015.01.003 · DOI
  11. S Thameem Dheen, 2007, Microglial Activation and its Implications in the Brain Diseases, Curr. Med. Chem, 14, 1189, 10.2174/092986707780597961 · DOI
  12. M Prinz, 2011, Microglia in the CNS: Immigrants from another world, Glia, 59, 177, 10.1002/glia.21104 · DOI
  13. F Ginhoux, 2010, Science, Science, 330, 841
  14. P Squarzoni, 2014, Microglia Modulate Wiring of the Embryonic Forebrain, Cell Rep, 8, 1271, 10.1016/j.celrep.2014.07.042 · DOI
  15. AH Stephan, 2012, The Complement System: An Unexpected Role in Synaptic Pruning During Development and Disease, Annu. Rev. Neurosci, 35, 369, 10.1146/annurev-neuro-061010-113810 · DOI · Paper page
  16. M Perez-Pouchoulen, 2015, Morphological and Phagocytic Profile of Microglia in the Developing Rat Cerebellum, eNeuro, 2, 1, 10.1523/ENEURO.0036-15.2015 · DOI
  17. EM York, 2018, Microglial modulation of neuronal activity in the healthy brain, Dev. Neurobiol, 78, 593, 10.1002/dneu.22571 · DOI · Paper page
  18. SA Wolf, 2017, Microglia in Physiology and Disease, Annu. Rev. Physiol, 79, 619, 10.1146/annurev-physiol-022516-034406 · DOI · Paper page
  19. GJ Harry, 2013, Microglia during development and aging, Pharmacol. Ther, 139, 313, 10.1016/j.pharmthera.2013.04.013 · DOI · Paper page
  20. CN Parkhurst, 2013, Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor, Cell, 155, 1596, 10.1016/j.cell.2013.11.030 · DOI · Paper page
  21. P Yuan, 2016, TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy, Neuron, 90, 724, 10.1016/j.neuron.2016.05.003 · DOI · Paper page
  22. L Ren, 1999, Differential expression of inflammatory mediators in rat microglia cultured from different brain regions, Mol. Brain Res, 65, 198, 10.1016/S0169-328X(99)00016-9 · DOI
  23. A Crotti, 2014, Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors, Nat. Neurosci, 17, 513, 10.1038/nn.3668 · DOI · Paper page
  24. PE Batchelor, 1999, Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor, J. Neurosci, 19, 1708, 10.1523/JNEUROSCI.19-05-01708.1999 · DOI
  25. T Wyss-Coray, 2001, TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice, Nat. Med, 7, 612, 10.1038/87945 · DOI · Paper page
  26. H Lian, 2016, Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer’s Disease, J. Neurosci, 36, 577, 10.1523/JNEUROSCI.2117-15.2016 · DOI · Paper page
  27. X Wang, 2005, Involvement of proinflammatory factors, apoptosis, caspase-3 activation and Ca2+ disturbance in microglia activation-mediated dopaminergic cell degeneration, Mech. Ageing Dev, 126, 1241, 10.1016/j.mad.2005.06.012 · DOI
  28. E. Burda Joshua, 2014, Reactive gliosis and the multicellular response to CNS damage and disease, Neuron, 81, 229, 10.1016/j.neuron.2013.12.034 · DOI
  29. CK Glass, 2010, Mechanisms Underlying Inflammation in Neurodegeneration, Cell, 140, 918, 10.1016/j.cell.2010.02.016 · DOI · Paper page
  30. A Aguzzi, 2013, Microglia: scapegoat, saboteur, or something else?, Science, 339, 156, 10.1126/science.1227901 · DOI · Paper page
  31. RM Ransohoff, 2016, A polarizing question: do M1 and M2 microglia exist?, Nat. Neurosci, 19, 987, 10.1038/nn.4338 · DOI · Paper page
  32. R Brambilla, 2011, Inhibition of soluble tumour necrosis factor encephalomyelitis and promotes axon preservation and remyelination, Brain, 34, 2736, 10.1093/brain/awr199 · DOI
  33. R Li, 2004, Tumor Necrosis Factor Death Receptor Signaling Cascade Is Required for Amyloid- Protein-Induced Neuron Death, J Neurosci, 24, 1760, 10.1523/JNEUROSCI.4580-03.2004 · DOI · Paper page
  34. K Sriram, 2006, Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-induced neurotoxicity: role of TNF-alpha, FASEB J, 20, 670, 10.1096/fj.05-5106com · DOI
  35. E Zandi, 1997, The IkB Kinase Complex (IKK) Contains Two Kinase Subunits, IKKa and IKKb, Necessary for IkB Phosphorylation and NF-kB Activation, Cell, 91, 243, 10.1016/S0092-8674(00)80406-7 · DOI
  36. MS Hayden, 2008, Shared Principles in NF-kB Signaling, Cell, 132, 344, 10.1016/j.cell.2008.01.020 · DOI
  37. H Zhong, 2002, The phosphorylation status of nuclear NF-kB determines its association with CBP/p300 or HDAC-1, Mol. Cell, 9, 625, 10.1016/S1097-2765(02)00477-X · DOI
  38. K Grabert, 2016, Microglial brain region − dependent diversity and selective regional sensitivities to aging, Nat Neurosci, 19, 504, 10.1038/nn.4222 · DOI · Paper page
  39. IH Cho, 2008, Role of microglial IKKB in kainic acid-induced hippocampal neuronal cell death, Brain, 131, 3019, 10.1093/brain/awn230 · DOI
  40. BE Clausen, 1999, Conditional gene targeting in macrophages and granulocytes using LysMcre mice, Transgenic Res, 8, 265, 10.1023/A:1008942828960 · DOI · Paper page
  41. EN Burright, 1995, SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat, Cell, 82, 937, 10.1016/0092-8674(95)90273-2 · DOI
  42. S-H Cho, 2015, Neurobiology of Disease SIRT1 Deficiency in Microglia Contributes to Cognitive Decline in Aging and Neurodegeneration via Epigenetic Regulation of IL-1b, J Neurosci, 35, 807, 10.1523/JNEUROSCI.2939-14.2015 · DOI · Paper page
  43. A Khoshnan, 2004, Activation of the I B Kinase Complex and Nuclear Factor- B Contributes to Mutant Huntingtin Neurotoxicity, J. Neurosci, 24, 7999, 10.1523/JNEUROSCI.2675-04.2004 · DOI
  44. W Qu, 2017, Inhibition of colony-stimulating factor 1 receptor early in disease ameliorates motor deficits in SCA1 mice, J. Neuroinflammation, 14, 1
  45. M Ingram, 2016, Cerebellar Transcriptome Profiles of ATXN1 Transgenic Mice Reveal SCA1 Disease Progression and Protection Pathways, Neuron, 89, 1194, 10.1016/j.neuron.2016.02.011 · DOI
  46. L Duvick, 2010, SCA1-like disease in mice expressing wild-type Ataxin-1 with a serine to aspartic acid replacement at residue 776, Neuron, 67, 929, 10.1016/j.neuron.2010.08.022 · DOI · Paper page
  47. V a. Gennarino, 2015, Pumilio1 haploinsufficiency leads to SCA1-like neurodegeneration by increasing wild-type Ataxin1 levels, Cell, 160, 1087, 10.1016/j.cell.2015.02.012 · DOI
  48. M Cvetanovic, 2011, Vascular endothelial growth factor ameliorates the ataxic phenotype in a mouse model of spinocerebellar ataxia type 1, Nat. Med, 17, 1445, 10.1038/nm.2494 · DOI
  49. JE Burda, 2014, Reactive gliosis and the multicellular response to CNS damage and disease, Neuron, 81, 229, 10.1016/j.neuron.2013.12.034 · DOI
  50. SA Liddelow, 2017, Neurotoxic reactive astrocytes are induced by activated microglia, Nature, 541, 481, 10.1038/nature21029 · DOI · Paper page
  51. K Hashimoto, 2005, Postnatal development and synapse elimination of climbing fiber to Purkinje cell projection in the cerebellum, Neurosci. Res, 53, 221, 10.1016/j.neures.2005.07.007 · DOI
  52. K Hashimoto, 2009, Translocation of a “‘ Winner ‘” Climbing Fiber to the Purkinje Cell Dendrite and Subsequent Elimination of “‘ Losers ‘” from the Soma in Developing Cerebellum, Neuron, 63, 106, 10.1016/j.neuron.2009.06.008 · DOI
  53. K Hashimoto, 2003, Functional differentiation of multiple climbing fiber inputs during synapse elimination in the developing cerebellum, Neuron, 38, 785, 10.1016/S0896-6273(03)00298-8 · DOI
  54. M Letellier, 2008, Normal adult climbing fiber monoinnervation of cerebellar Purkinje cells in mice lacking MHC class I molecules, Dev. Neurobiol, 68, 997, 10.1002/dneu.20639 · DOI
  55. C Chen, 1995, Impaired motor coordination correlates with persistent multiple climbing fiber innervation in PKC mutant mice, Cell, 83, 1233, 10.1016/0092-8674(95)90148-5 · DOI
  56. M Paukert, 2014, Norepinephrine controls astroglial responsiveness to local circuit activity, Neuron, 82, 1263, 10.1016/j.neuron.2014.04.038 · DOI · Paper page
  57. B Sensitization, 2016, Microglial TNF- a Suppresses Cocaine-Induced Plasticity and Behavioral Sensitization, Neuron, 90, 1
  58. LM Sedger, 2014, TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants—past, present and future, Cytokine Growth Factor Rev, 25, 453, 10.1016/j.cytogfr.2014.07.016 · DOI
  59. MJ Lee, 2016, IKKβ-mediated inflammatory myeloid cell activation exacerbates experimental autoimmune encephalomyelitis by potentiating Th1/Th17 cell activation and compromising blood brain barrier, Mol. Neurodegener, 11, 1
  60. MC Arkan, 2005, IKK-beta links inflammation to obesity-induced insulin resistance, Nat. Med, 11, 191, 10.1038/nm1185 · DOI · Paper page
  61. SH Kwon, 2017, Dysfunction of microglial STAT3 alleviates depressive behavior via neuron-microglia interactions, Neuropsychopharmacology, 42, 2072, 10.1038/npp.2017.93 · DOI · Paper page
  62. MJ Lee, 2016, IKKβ-mediated inflammatory myeloid cell activation exacerbates experimental autoimmune encephalomyelitis by potentiating Th1/Th17 cell activation and compromising blood brain barrier, Mol. Neurodegener, 11, 1
  63. SS Minami, 2014, Progranulin protects against amyloid β deposition and toxicity in Alzheimer’s disease mouse models, Nat. Med, 20, 1157, 10.1038/nm.3672 · DOI · Paper page
  64. B Liao, 2012, Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS, Exp. Neurol, 237, 147, 10.1016/j.expneurol.2012.06.011 · DOI
  65. RD Stowell, 2018, Cerebellar microglia are dynamically unique and survey Purkinje neurons in vivo, Dev. Neurobiol, 1
  66. M Pekny, 2016, Astrocytes: a central element in neurological diseases, Acta Neuropathol, 131, 323, 10.1007/s00401-015-1513-1 · DOI
  67. M V Sofroniew, 2010, Vinters H V. Astrocytes: Biology and pathology, Acta Neuropathol, 119, 7, 10.1007/s00401-009-0619-8 · DOI · Paper page
  68. FR Greten, 2004, IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer, Cell, 118, 285, 10.1016/j.cell.2004.07.013 · DOI · Paper page
  69. Z-W Li, 2003, IKK Is Required for Peripheral B Cell Survival and Proliferation, J. Immunol, 170, 4630, 10.4049/jimmunol.170.9.4630 · DOI
  70. S Mincheva-Tasheva, 2013, NF- B Signaling Pathways: Role in Nervous System Physiology and Pathology, Neuroscientist, 19, 175, 10.1177/1073858412444007 · DOI
  71. J Orthgiess, 2016, Neurons exhibit Lyz2 promoter activity in vivo: Implications for using LysM-Cre mice in myeloid cell research, Eur. J. Immunol, 46, 1529, 10.1002/eji.201546108 · DOI
  72. CL Abram, 2015, Comparative analysis of the efficiency and specificity of myeloid-Cre deleting strains using ROSA-EYFP reporter mice, J Immunol Methods, 408, 89, 10.1016/j.jim.2014.05.009 · DOI
  73. M Ye, 2003, Hematopoietic stem cells expressing the myeloid lysozyme gene retain long-term, multilineage repopulation potential, Immunity, 19, 689, 10.1016/S1074-7613(03)00299-1 · DOI
  74. M Cvetanovic, 2011, Vascular endothelial growth factor ameliorates the ataxic phenotype in a mouse model of spinocerebellar ataxia type 1, Nat Med, 17, 1445, 10.1038/nm.2494 · DOI
  75. M Cvetanovic, 2015, Decreased Expression of Glutamate Transporter GLAST in Bergmann Glia Is Associated with the Loss of Purkinje Neurons in the Spinocerebellar Ataxia Type 1, Cerebellum, 14, 8, 10.1007/s12311-014-0605-0 · DOI

Cited by

Sorted by citations

Metadata

Authors
Ferro, A., Qu, W., Lukowicz, A., Svedberg, D., Johnson, A., & Cvetanovic, M.
ORCID
Venue
PLOS ONE
Publisher
Public Library of Science (PLoS)
Published
2018-07-05
Volume
13
Issue
7
Pages
e0200013
ISSN
1932-6203
DOI
10.1371/journal.pone.0200013
PMC
PMC6033432
Cited by
26
References
10
Language
en
Licence
creativecommons.org/licenses/by/4.0/ (vor)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review